Related Experiment Video
Updated: Aug 27, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Outcomes of Candida and Non-Candida Aortic Graft Infection
Safwan Omran1, Steffen Gröger1, Bashaer Shafei1
1Department of Vascular Surgery, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 14903Charité--Universitätsmedizin Berlin, Berlin, Germany.
Insights
Candida-associated aortic graft infections led to longer hospital stays but similar mortality rates compared to non-Candida infections. This study highlights key differences in outcomes for patients with fungal versus bacterial aortic graft infections.
Area of Science:
- Cardiovascular Surgery
- Infectious Diseases
- Medical Microbiology
Background:
- Aortic graft infection is a severe complication following aortic reconstructive surgery.
- Distinguishing between fungal (Candida) and bacterial etiologies is crucial for understanding disease progression and outcomes.
Purpose of the Study:
- To compare the clinical outcomes of aortic graft infections caused by Candida species versus non-Candida pathogens.
- To identify specific risk factors and clinical presentations associated with Candida-related aortic graft infections.
Main Methods:
- Retrospective analysis of 66 patients diagnosed with aortic graft infection between 2015 and 2021.
- Categorization of patients into Candida (n=21) and non-Candida (n=45) groups.
- Comparison of demographic data, clinical presentation, treatment, and outcomes, including length of stay and mortality.
Main Results:
- Graft-enteric fistulas were more prevalent in the Candida group (57% vs. 27%, P=.017).
- Candida albicans was the most common fungal isolate.
- Patients with Candida infections experienced significantly longer ICU (10 vs. 9 days, P=.012) and hospital stays (33 vs. 22 days, P=.048).
- No significant differences in in-hospital or 1-year mortality were observed between the groups.
Conclusions:
- Both Candida and non-Candida aortic graft infections are associated with high morbidity and mortality.
- While Candida infections do not appear to increase mortality risk, they are linked to prolonged hospitalizations.
- Further research into targeted antifungal strategies may be warranted.
Objective:
To evaluate and compare the outcomes of Candida- and non-Candida-associated aortic graft infections.
Methods:
We retrospectively analyzed the data from patients treated for aortic graft infection from 2015 to 2021 in our hospital.
Results:
A total of 66 patients (56 men; median age, 69 years; range, 50-87 years) were admitted with aortic graft infection, including 21 (32%) patients in the Candida group and 45 (68%) in the non-Candida group. The average time between initial operation and presentation of aortic graft infection was 50 months (range, 1-332 months). Graft-enteric fistulas (GEFs) were more often in the Candida group (57% vs 27%, P = .017). The most proven causative fungal specimen was C. albicans in 16 (76%) patients. Non-albicans Candida was found in 9% of all patients and 29% of the Candida patients. The median ICU length of stay was longer in the Candida group than non-Candida (10 vs 9 days, P = .012). Additionally, the median hospital length of stay was longer in the Candida group (33 vs 22 days, P = .048). There were no statistically significant differences between Candida and non-Candida groups according to the in-hospital mortality (24% vs 24%, P = .955), and 1-year mortality (38% vs 38%, P = .980).
Conclusions:
Patients with bacterial and fungal aortic graft infections have high rates of morbidity and mortality. We found no significant differences in postoperative morbidity and mortality between Candida and non-Candida patients. However, the ICU and hospital length of stay were longer in the Candida group.
Related Concept Videos
Aneurysm III: Interprofessional Care
Endocarditis III: Medical Management
Aortic Regurgitation I: Introduction
Endocarditis I: Introduction
Aneurysm IV: Nursing Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

